Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone liposome in HER2-negative advanced breast cancer
CTR20211172Phase 2Terminated
- Sponsor
- CSPC Pharmaceutical Group
- Start
- May 2021
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mitoxantrone in breast cancer, sponsored by CSPC Pharmaceutical Group. Started May 2021; status: terminated.
02
Drugs
mitoxantrone
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20211172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211172.